San Francisco–(work wire) – Tivic Health Systems, Inc. (Nasdaq: TIVC), a startup focused on non-invasive bioelectronic medicine, is calling Mindgruve, a modern marketing agency, its digital marketing agency. Mindgruve will work with Tivic Health to develop an integrated marketing and branding strategy that supports marketing and sales efforts in the United States
Tivic Health develops bioelectronic and non-pharmaceutical electronic products to treat diseases and help individuals improve their quality of life. ClearUP® Sinus Pain Relief is the company’s first patented product to use low-level electron waves to relieve sinus pain and congestion, common symptoms of sinus and nasal inflammation.
“We selected Mindgruve based on its extensive experience helping consumer and health brands build successful businesses,” said Jennifer Ernst, CEO of Tivic Health. “They will focus on improving our e-commerce platforms, digital and social marketing, comprehensive brand development, and raising awareness of vital online options for treating disease and improving health.”
“We are excited to work with the Tivic Health team to build a compelling brand in bioelectronic medicine, with a key product in the large and growing sinus care market,” said Chad Robley, CEO and founder of Mindgruve.
Mindgruve is a global, independent marketing agency made up of strategists, innovators, media experts, data scientists and engineers from around the world driven by one common goal – to create a groundbreaking business that helps brands drive business growth. For more information, visit https://mindgruve.com/
About Tivic Health Systems, Inc.
Tyvic Health Systems, Inc. is a commercial-stage health technology company that advances bioelectronic medicine to deliver non-invasive solutions that treat disease, increase wellness, and improve lives. The company develops non-invasive products that offer consumers a choice in treating infections and related conditions. For more information, please visit https://tivichealth.comTivicHealth
This press release may contain “forward-looking statements” that are subject to significant risks and uncertainties. All statements, other than statements of historical facts, contained in this press release are forward-looking statements. The forward-looking statements made in this press release may be identified by the use of words such as “expect,” “believe,” “think,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” may,” “plan,” “likely,” “expect,” “project,” “goal,” “goal,” “should,” “will,” “will,” or the negative of these or other similar expressions, Although not all forward-looking statements contain these words.Forward-looking statements are based on current expectations of Tivic Health Systems, Inc. and are subject to inherent uncertainties, risks and assumptions that are difficult to predict.Furthermore, some forward-looking statements are based on assumptions regarding future events that may not Additional information regarding Tivic Health and its business, including a discussion of factors that could materially affect the company’s operating results, is contained in the company’s registration statement on Form S-1 (and amendments thereto) under the heading “Risk Factors,” also as Subsequent company files with the Securities and Exchange Commission.The forward-looking statements contained in this announcement are made as of this date, and they do not assume Tivic Health Systems, Inc. No duty to update this information except as required by applicable law.